Heartbeat Health, a NYC-based healthcare company working to deliver heart care, raised $20m in Series B funding.
The round was led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures. Jessica Zeaske, a Partner at Echo Health Ventures, will join the Board of Directors at Heartbeat.
The company intends to use the funds to accelerate product research and development as well as expand clinical services offered to at-risk organizations.
Led by Dr. Jeff Wessler, CEO, Nayan Jain, CTO, and Mark Hanson, Chief Product Officer, Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management with a focus on improved clinical experience, health outcomes, and reduced cost. The Heartbeat virtual-first platform offers a data-powered patient and provider experience, combining telemedicine, diagnost
Insurtech: Vericred Raises $23 Million in Series B Round crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Healthcare startups that had a breakout year in 2020 are poised to have an even better 2021, investors told Business Insider.
Startups, especially those focused on virtual care benefitted from being in the right place at the right time amid the global pandemic.
Business Insider interviewed dozens of venture capitalists and other private investors to learn which startups are poised to take off in 2021.
Looking back, 2020 will likely mark a sea change for healthcare startups.
Many startups saw a pandemic-sized opportunity and took advantage of new technology and newly agile hospitals and clinics to break into the notoriously difficult field.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
We asked healthcare and biotech venture capitalists from leading firms like Venrock and NEA to share their predictions for 2021.
2020 was a pivotal year for healthcare, shaped by the pandemic and a booming IPO market for digital health companies.
In 2021, VCs are anticipating a rough time for young startups, a big year for digital health IPOs, and increased attention for startups looking to address the healthcare industry s shortcomings.
It s difficult to imagine what 2021 has in store, after a pandemic-ravaged 2020.
But when it comes to the healthcare industry, investors are predicting certain events and trends are bound to transpire in the coming year.